Rosholm J U, Hansen L J, Hallas J, Gram L F
Department of Clinical Pharmacology, Odense University, Denmark.
Br J Clin Pharmacol. 1993 Dec;36(6):579-83. doi: 10.1111/j.1365-2125.1993.tb00418.x.
1 A prescription database study was conducted to describe the out-patient utilization of neuroleptics in the Odense area (207,000 inhabitants) during a period of 1 year. 2 Neuroleptic drug use is widespread, the period prevalence being 2.45% of the population. 3 The prevalence increases with increasing age. Fifteen percent of the population aged 90 years or more received neuroleptic drugs in spite of the many warnings against side effects in the elderly. 4 Estimated daily doses of neuroleptics were considerably lower than the Defined Daily Dose, probably as a reflection of many neuroleptics being prescribed to non-psychotic patients, in whom lower doses are used. 5 For perphenazine, a comparison of estimated daily doses from this study with doses from patients whose treatment had been adjusted by plasma concentration monitoring showed that generally much lower doses were used by patients included in this study.
开展了一项处方数据库研究,以描述欧登塞地区(20.7万居民)在1年期间抗精神病药物的门诊使用情况。
抗精神病药物的使用很普遍,期间患病率为人口的2.45%。
患病率随年龄增长而增加。尽管对老年人的副作用有诸多警告,但90岁及以上人群中有15%使用了抗精神病药物。
抗精神病药物的估计日剂量远低于限定日剂量,这可能反映出许多抗精神病药物是开给非精神病患者的,这些患者使用的剂量较低。
对于奋乃静,将本研究的估计日剂量与通过血浆浓度监测调整治疗的患者的剂量进行比较后发现,本研究纳入的患者通常使用的剂量要低得多。